Vince Anzalone
Senior Vice President of Investor Relations
Replay available
Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2026 Earnings Call
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q2 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Chris Anzalone
President and Chief Executive Officer
Andy Davis
Senior Vice President and Head of the Global Cardiometabolic Franchise
Dr. James Hamilton
Chief Medical Officer and Head of R&D
Dan Appel
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arrowhead Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425b-5130-7f60-9d5d-2fde47dfcbbf Created: 2026-08-27T08:34:38.306Z Duration: 3622.8962 Channels: 1 00:00:00.000 -- 00:00:01.359 Ladies and gentlemen, 00:00:01.520 -- 00:00:03.679 welcome to the Arrowhead Pharmaceuticals 00:00:03.679 -- 00:00:04.800 Conference Call. 00:00:05.120 -- 00:00:07.360 Throughout today's presentation, 00:00:07.919 -- 00:00:09.040 all participants 00:00:09.040 -- 00:00:11.039 will be in listen only mode. 00:00:11.360 -- 00:00:12.480 After the presentation, 00:00:13.165 -- 00:00:16.125 there will be an opportunity to ask questions. 00:00:16.525 -- 00:00:19.165 Instructions will follow at that time. I will 00:00:19.165 -- 00:00:21.645 now hand the conference call over to Vince 00:00:21.645 -- 00:00:22.605 Anzalone, 00:00:22.765 -- 00:00:26.365 Senior Vice President of Investor Relations for Arrowhead. 00:00:26.365 -- 00:00:27.564 Please go ahead, Vince. 00:00:29.880 -- 00:00:31.720 Good afternoon and thank you for joining us 00:00:31.720 -- 00:00:34.280 today to discuss Arrowhead's results for its fiscal 00:00:34.280 -- 00:00:38.680 twenty twenty six second quarter ended 03/31/2026. 00:00:39.000 -- 00:00:41.559 With us today from management are President and 00:00:41.559 -- 00:00:43.079 CEO, Doctor. Chris Anzalone, 00:00:43.445 -- 00:00:46.245 who will provide an overview Andy Davis, Senior 00:00:46.245 -- 00:00:48.805 Vice President and Head of the Global CardioVentabolic 00:00:48.805 -- 00:00:49.685 Franchise, 00:00:49.845 -- 00:00:52.645 who will provide an update on commercialization activities 00:00:52.805 -- 00:00:55.365 Doctor. James Hamilton, Chief Medical Officer and Head 00:00:55.365 -- 00:00:57.125 of R and D, who will discuss our 00:00:57.125 -- 00:00:58.245 development p...